Patient Power®
Get Email Alerts!
Health Topics
Prostate Cancer Health Center
Health Center Home Audio Programs Videos
Search by Keyword:
Search by Health Topic:
View all Health Topics >
Spring Survey 2012

Advances in the Treatment of Prostate Cancer

PROGRAM DETAILS:

There are many prostate cancer treatment choices available today that enable a high quality of life during and after treatment. This Patient Power program includes a discussion of robotic surgery, minimally invasive surgery, proton therapy and other methods used in the treatment of prostate cancer. Learn more about hormone therapy, radiation, targeted therapy, clinical trials for prostate cancer and why the future is promising for men with prostate cancer.

Two prostate cancer survivors, each treated at M. D. Anderson Cancer Center, speak candidly about their different experiences while being treated. Sam had a high PSA that led to his diagnosis. He participated in a clinical trial and today leads a normal lifestyle. Joseph, a 66-year old survivor, had symptoms that were masked by his diabetes, urinary and circulatory issues. His wife convinced him to get a prostate cancer check at an M. D. Anderson awareness program and, through that check-up, he was referred to a urologist. He then saw Dr. Kuban, was treated with hormone therapy, and he too is living well today with a nondetectable PSA level.

You’ll also hear from two leading experts as they join Andrew to discuss Prostate Cancer. Dr. Deborah Kuban, professor of radiation oncology, explains exactly what prostate specific antigen (PSA) is and why it’s important in the detection of prostate cancer. She discusses the importance of technology and how doctors are able to target treatment to each patient’s tumor. Dr. John Ward, a urologist and surgical oncologist, talks about advances in the treatment of prostate cancer using both robotic surgery and the advances in radiation therapy with the aid of computers. Learn about progress being made in drug therapy and why the clinical trials and research taking place at M. D. Anderson are important for the future. There are many prostate cancer treatment choices available today that enable a high quality of life during and after treatment. This Patient Power program includes a discussion of robotic surgery, minimally invasive surgery, proton therapy and other methods used in the treatment of prostate cancer. Learn more about hormone therapy, radiation, targeted therapy, clinical trials for prostate cancer and why the future is promising for men with prostate cancer.

Two prostate cancer survivors, each treated at M. D. Anderson Cancer Center, speak candidly about their different experiences while being treated. Sam had a high PSA that led to his diagnosis. He participated in a clinical trial and today leads a normal lifestyle. Joseph, a 66-year old survivor, had symptoms that were masked by his diabetes, urinary and circulatory issues. His wife convinced him to get a prostate cancer check at an M. D. Anderson awareness program and, through that check-up, he was referred to a urologist. He then saw Dr. Kuban, was treated with hormone therapy, and he too is living well today with a nondetectable PSA level.

You’ll also hear from two leading experts as they join Andrew to discuss Prostate Cancer. Dr. Deborah Kuban, professor of radiation oncology, explains exactly what prostate specific antigen (PSA) is and why it’s important in the detection of prostate cancer. She discusses the importance of technology and how doctors are able to target treatment to each patient’s tumor. Dr. John Ward, a urologist and surgical oncologist, talks about advances in the treatment of prostate cancer using both robotic surgery and the advances in radiation therapy with the aid of computers. Learn about progress being made in drug therapy and why the clinical trials and research taking place at M. D. Anderson are important for the future.

Get Email Updates:

Get updated automatically when new content about Prostate Cancer has been posted.
Privacy Policy
Prostate CancerMore Health Topics
EXPERTS & GUESTS:
Debbie Kuban, M.D., F.A.C.R. Debbie Kuban, M.D., F.A.C.R.
Professor of Radiation Oncology, MD Anderson Cancer Center
Dr. Kuban serves as Professor of Radiation Oncology and Program Director and Section Chief of Genitourinary Radiation Oncology at The University of Texas M.D. Anderson Cancer Center. She received her medical degree from the Medical College of Georgia in Atlanta and completed her residency training at Eastern Virginia Medical School. Dr. Kuban’s resume boasts an extensive list of achievements: she’s... more >

John Ward, M.D., F.A.C.S.
Assistant Professor, Department of Urology
Dr. Ward is Assistant Professor in the Department of Urology at The University of Texas M.D. Anderson Cancer Center. He received his medical degree from Georgetown University, completed his residency in urology at the Naval Medical Center in San Diego and completed a fellowship in urologic oncology at the mayo Clinic in Rochester, Minnesota. more >

TRANSCRIPT:

  1. Introduction
  2. Prostate Cancer Survivor Stories
  3. Dr. Kuban Explains the PSA Test
  4. Dr. John Ward Discusses Treatment
  5. Robotic Surgery for Prostate Cancer
  6. Radiation Treatment
  7. Radiation and Computer Technology: Targeting Treatment
  8. Risk of Prostate Cancer Recurrence
  9. Assessing Your Risk
  10. The Selenium Study
  11. Benign Prostatic Hyperplasia
  12. Hormone Therapy
  13. Prostate Cancer Research at M. D. Anderson
  14. Progress in Drug Therapy

RELATED LINKS: